Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03152474Phase 4Completed
Phase 4, randomised, double-blind trial of methylprednisolone injection and vitamin a in sepsis and septic shock (3 arms), sponsored by The Lundquist Institute. Primary endpoint: 28 days mortality. Started Feb 1993; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03152474.